LUCD: Lucid Diagnostics Inc. Stock

by  •  • Comments Off on LUCD: Lucid Diagnostics Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 132.43
Enterprise Value ($M) 183.09
Book Value ($M) 5.39
Book Value / Share 0.05
Price / Book 24.56
NCAV ($M) -0.18
NCAV / Share -0.00
Price / NCAV -752.43

Profitability (mra)
Return on Invested Capital (ROIC) -1.71
Return on Assets (ROA) -1.42
Return on Equity (ROE) -3.83

Liquidity (mrq)
Quick Ratio 1.05
Current Ratio 1.07

Balance Sheet (mrq) ($M)
Current Assets 25.15
Assets 30.71
Liabilities 25.32
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4.35
Operating Income -46.05
Net Income -45.53
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -44.14
Cash from Investing -0.65
Cash from Financing 48.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Ayrton Capital LLC 2.00 -75.78

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 144,813 858,701 16.86
2025-04-28 157,653 747,818 21.08
2025-04-25 484,673 1,267,691 38.23
2025-04-24 426,238 1,881,829 22.65

(click for more detail)

Similar Companies
LFWD – Lifeward Ltd. LGMK – LogicMark, Inc.
LNSR – LENSAR, Inc. LYRA – Lyra Therapeutics, Inc.
MBOT – Microbot Medical Inc.


Financial data and stock pages provided by
Fintel.io